AI Boom May Keep Real Estate Borrowing Costs Elevated, Break of Day Capital Says
Bitget2026/11/02 19:48- Break of Day Capital warned AI infrastructure spending could keep multifamily financing costs elevated, even if the Federal Reserve cuts rates.
- Major hyperscalers are expected to issue approximately $279 billion in corporate bonds in 2026, versus $17 billion in 2024, intensifying capital competition.
- The Fed held its benchmark rate at 3.75%-4% on October 28, 2026, as inflation remained elevated.
- The 10-year Treasury yield remained near or above 5%, pressuring commercial real estate valuations, according to CBRE’s October 2026 analysis.
- Multifamily investors should prioritize conservative underwriting, manageable debt structures and adequate reserves rather than rely on future rate cuts.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
BUZZ - Rocket Lab’s stock falls as quarterly loss exceeds expectations
BUZZ-Take-Two shares rise after raising annual revenue and profit forecasts
Itaúsa Q3 2026 recurring net profit rises 25% to R$ 5.06 billion year-on-year
The US FDA requires semaglutide, tirzepatide, and other GLP-1 drugs to include new warnings about the risk of eye disease.
NAION is an eye disease that can cause sudden, painless loss of vision, with some patients potentially experiencing permanent visual impairment. The drugs involved include products from Eli Lilly and Novo Nordisk. According to analysts at Citi, the incidence of NAION is relatively low, and given the significant benefits of GLP-1 drugs in weight control and blood sugar management, the actual impact on prescription behavior is expected to be limited. On Monday, the stock prices of Eli Lilly and Novo Nordisk increased, with the news not causing any significant impact on their share prices.
Crypto prices
More
